2025 Pharmaceutical Companies Pharmaceutical Manufacturing 
European Pharmaceutical Review
JUNE 10, 2024
The first industrial-scale pharmaceutical manufacturing facility for production of lead-212-based radioligand therapies has been inaugurated. The company hopes to produce this number tenfold by the end of 2030. billion.
HealthPartners
MAY 5, 2021
They may keep or pass through a percentage of prescription drug rebates paid by pharmaceutical companies in return for placing their drugs on the plan’s formulary (list of preferred drugs). Other drug sales-related incentive payments from drug manufacturers to the PBM may not be disclosed or passed through. billion by 2025.
Expert insights. Personalized for you.
98 
Let's personalize your content